Tucson AZ 胰腺癌临床试验
7项针对 胰腺癌的研究正在 Tucson及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
招募中3 期
- The University of Arizona Cancer Center-North Campus, Tucson
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
招募中3 期
- Investigative Site US045, Tucson
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
招募中3 期
- University of Arizona Cancer Center - North Campus, Tucson
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
招募中早期 I 期
- University of Arizona Cancer Center, Tucson
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
招募中2 期
- Arizona Clinical Research Center, Tucson
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
招募中2 期
- Ohio State University-Telemedicine, Tucson
PROMs After Pancreatectomy
招募中观察性研究
- The University of Arizona, Tucson
其他城市的 胰腺癌试验
- Houston, TX61 项研究
- New York City, NY60 项研究
- Boston, MA43 项研究
- Nashville, TN39 项研究
- Los Angeles, CA35 项研究
- St. Louis, MO33 项研究
- Arlington, VA33 项研究
- San Antonio, TX31 项研究
- Baltimore, MD30 项研究
- Philadelphia, PA26 项研究
- Tampa, FL26 项研究
- Durham, NC24 项研究
Tucson的其他研究
- 乳腺癌19 项研究
- 肥胖症18 项研究
- 非小细胞肺癌17 项研究
- 超重15 项研究
- 转移性癌症14 项研究
- 心血管疾病12 项研究
- 癌症（所有类型）12 项研究
- 2型糖尿病11 项研究
- 结直肠癌11 项研究
- 前列腺癌11 项研究
- 高血压10 项研究
- 心力衰竭10 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月7日。每项研究自行设定入选标准，由研究团队决定谁能参与。